Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
161,353
archived clinical trials in
Cancer

Morphotek Investigation in Colorectal Cancer: Research of MORAb-004 (MICRO)
A Randomized, Double-Blind, Placebo-controlled Study of the Efficacy & Safety of Monotherapy MORAb-004 Plus Best Supportive Care in Subjects With Chemorefractory Metastatic Colorectal Cancer
Status: Enrolling
Updated:  9/4/2015
Pharma Resource
mi
from
East Providence, RI
Morphotek Investigation in Colorectal Cancer: Research of MORAb-004 (MICRO)
A Randomized, Double-Blind, Placebo-controlled Study of the Efficacy & Safety of Monotherapy MORAb-004 Plus Best Supportive Care in Subjects With Chemorefractory Metastatic Colorectal Cancer
Status: Enrolling
Updated: 9/4/2015
Pharma Resource
mi
from
East Providence, RI
Click here to add this to my saved trials
Morphotek Investigation in Colorectal Cancer: Research of MORAb-004 (MICRO)
A Randomized, Double-Blind, Placebo-controlled Study of the Efficacy & Safety of Monotherapy MORAb-004 Plus Best Supportive Care in Subjects With Chemorefractory Metastatic Colorectal Cancer
Status: Enrolling
Updated:  9/4/2015
Rhode Island Hospital
mi
from
Providence, RI
Morphotek Investigation in Colorectal Cancer: Research of MORAb-004 (MICRO)
A Randomized, Double-Blind, Placebo-controlled Study of the Efficacy & Safety of Monotherapy MORAb-004 Plus Best Supportive Care in Subjects With Chemorefractory Metastatic Colorectal Cancer
Status: Enrolling
Updated: 9/4/2015
Rhode Island Hospital
mi
from
Providence, RI
Click here to add this to my saved trials
Morphotek Investigation in Colorectal Cancer: Research of MORAb-004 (MICRO)
A Randomized, Double-Blind, Placebo-controlled Study of the Efficacy & Safety of Monotherapy MORAb-004 Plus Best Supportive Care in Subjects With Chemorefractory Metastatic Colorectal Cancer
Status: Enrolling
Updated:  9/4/2015
St. Vincent Hospital/Green Bay Oncology
mi
from
Green Bay, WI
Morphotek Investigation in Colorectal Cancer: Research of MORAb-004 (MICRO)
A Randomized, Double-Blind, Placebo-controlled Study of the Efficacy & Safety of Monotherapy MORAb-004 Plus Best Supportive Care in Subjects With Chemorefractory Metastatic Colorectal Cancer
Status: Enrolling
Updated: 9/4/2015
St. Vincent Hospital/Green Bay Oncology
mi
from
Green Bay, WI
Click here to add this to my saved trials
Morphotek Investigation in Colorectal Cancer: Research of MORAb-004 (MICRO)
A Randomized, Double-Blind, Placebo-controlled Study of the Efficacy & Safety of Monotherapy MORAb-004 Plus Best Supportive Care in Subjects With Chemorefractory Metastatic Colorectal Cancer
Status: Enrolling
Updated:  9/4/2015
St. Mary's Hospital / Green Bay Oncology
mi
from
Green Bay, WI
Morphotek Investigation in Colorectal Cancer: Research of MORAb-004 (MICRO)
A Randomized, Double-Blind, Placebo-controlled Study of the Efficacy & Safety of Monotherapy MORAb-004 Plus Best Supportive Care in Subjects With Chemorefractory Metastatic Colorectal Cancer
Status: Enrolling
Updated: 9/4/2015
St. Mary's Hospital / Green Bay Oncology
mi
from
Green Bay, WI
Click here to add this to my saved trials
Morphotek Investigation in Colorectal Cancer: Research of MORAb-004 (MICRO)
A Randomized, Double-Blind, Placebo-controlled Study of the Efficacy & Safety of Monotherapy MORAb-004 Plus Best Supportive Care in Subjects With Chemorefractory Metastatic Colorectal Cancer
Status: Enrolling
Updated:  9/4/2015
Christiana Care Health Services, Inc
mi
from
Newark, DE
Morphotek Investigation in Colorectal Cancer: Research of MORAb-004 (MICRO)
A Randomized, Double-Blind, Placebo-controlled Study of the Efficacy & Safety of Monotherapy MORAb-004 Plus Best Supportive Care in Subjects With Chemorefractory Metastatic Colorectal Cancer
Status: Enrolling
Updated: 9/4/2015
Christiana Care Health Services, Inc
mi
from
Newark, DE
Click here to add this to my saved trials
Morphotek Investigation in Colorectal Cancer: Research of MORAb-004 (MICRO)
A Randomized, Double-Blind, Placebo-controlled Study of the Efficacy & Safety of Monotherapy MORAb-004 Plus Best Supportive Care in Subjects With Chemorefractory Metastatic Colorectal Cancer
Status: Enrolling
Updated:  9/4/2015
Compass Research, LLC
mi
from
Orange City, FL
Morphotek Investigation in Colorectal Cancer: Research of MORAb-004 (MICRO)
A Randomized, Double-Blind, Placebo-controlled Study of the Efficacy & Safety of Monotherapy MORAb-004 Plus Best Supportive Care in Subjects With Chemorefractory Metastatic Colorectal Cancer
Status: Enrolling
Updated: 9/4/2015
Compass Research, LLC
mi
from
Orange City, FL
Click here to add this to my saved trials
Morphotek Investigation in Colorectal Cancer: Research of MORAb-004 (MICRO)
A Randomized, Double-Blind, Placebo-controlled Study of the Efficacy & Safety of Monotherapy MORAb-004 Plus Best Supportive Care in Subjects With Chemorefractory Metastatic Colorectal Cancer
Status: Enrolling
Updated:  9/4/2015
Cancer Care Centers of Brevard
mi
from
Rockledge, FL
Morphotek Investigation in Colorectal Cancer: Research of MORAb-004 (MICRO)
A Randomized, Double-Blind, Placebo-controlled Study of the Efficacy & Safety of Monotherapy MORAb-004 Plus Best Supportive Care in Subjects With Chemorefractory Metastatic Colorectal Cancer
Status: Enrolling
Updated: 9/4/2015
Cancer Care Centers of Brevard
mi
from
Rockledge, FL
Click here to add this to my saved trials
Morphotek Investigation in Colorectal Cancer: Research of MORAb-004 (MICRO)
A Randomized, Double-Blind, Placebo-controlled Study of the Efficacy & Safety of Monotherapy MORAb-004 Plus Best Supportive Care in Subjects With Chemorefractory Metastatic Colorectal Cancer
Status: Enrolling
Updated:  9/4/2015
Suburban Hematology-Oncology Associates
mi
from
Snellville, GA
Morphotek Investigation in Colorectal Cancer: Research of MORAb-004 (MICRO)
A Randomized, Double-Blind, Placebo-controlled Study of the Efficacy & Safety of Monotherapy MORAb-004 Plus Best Supportive Care in Subjects With Chemorefractory Metastatic Colorectal Cancer
Status: Enrolling
Updated: 9/4/2015
Suburban Hematology-Oncology Associates
mi
from
Snellville, GA
Click here to add this to my saved trials
Morphotek Investigation in Colorectal Cancer: Research of MORAb-004 (MICRO)
A Randomized, Double-Blind, Placebo-controlled Study of the Efficacy & Safety of Monotherapy MORAb-004 Plus Best Supportive Care in Subjects With Chemorefractory Metastatic Colorectal Cancer
Status: Enrolling
Updated:  9/4/2015
Illinois Cancercare, Pc
mi
from
Peoria, IL
Morphotek Investigation in Colorectal Cancer: Research of MORAb-004 (MICRO)
A Randomized, Double-Blind, Placebo-controlled Study of the Efficacy & Safety of Monotherapy MORAb-004 Plus Best Supportive Care in Subjects With Chemorefractory Metastatic Colorectal Cancer
Status: Enrolling
Updated: 9/4/2015
Illinois Cancercare, Pc
mi
from
Peoria, IL
Click here to add this to my saved trials
Morphotek Investigation in Colorectal Cancer: Research of MORAb-004 (MICRO)
A Randomized, Double-Blind, Placebo-controlled Study of the Efficacy & Safety of Monotherapy MORAb-004 Plus Best Supportive Care in Subjects With Chemorefractory Metastatic Colorectal Cancer
Status: Enrolling
Updated:  9/4/2015
John Hopkins University
mi
from
Baltimore, MD
Morphotek Investigation in Colorectal Cancer: Research of MORAb-004 (MICRO)
A Randomized, Double-Blind, Placebo-controlled Study of the Efficacy & Safety of Monotherapy MORAb-004 Plus Best Supportive Care in Subjects With Chemorefractory Metastatic Colorectal Cancer
Status: Enrolling
Updated: 9/4/2015
John Hopkins University
mi
from
Baltimore, MD
Click here to add this to my saved trials
Morphotek Investigation in Colorectal Cancer: Research of MORAb-004 (MICRO)
A Randomized, Double-Blind, Placebo-controlled Study of the Efficacy & Safety of Monotherapy MORAb-004 Plus Best Supportive Care in Subjects With Chemorefractory Metastatic Colorectal Cancer
Status: Enrolling
Updated:  9/4/2015
Henry Ford Health System
mi
from
Detroit, MI
Morphotek Investigation in Colorectal Cancer: Research of MORAb-004 (MICRO)
A Randomized, Double-Blind, Placebo-controlled Study of the Efficacy & Safety of Monotherapy MORAb-004 Plus Best Supportive Care in Subjects With Chemorefractory Metastatic Colorectal Cancer
Status: Enrolling
Updated: 9/4/2015
Henry Ford Health System
mi
from
Detroit, MI
Click here to add this to my saved trials
Morphotek Investigation in Colorectal Cancer: Research of MORAb-004 (MICRO)
A Randomized, Double-Blind, Placebo-controlled Study of the Efficacy & Safety of Monotherapy MORAb-004 Plus Best Supportive Care in Subjects With Chemorefractory Metastatic Colorectal Cancer
Status: Enrolling
Updated:  9/4/2015
The Mayo Clinic
mi
from
Rochester, MN
Morphotek Investigation in Colorectal Cancer: Research of MORAb-004 (MICRO)
A Randomized, Double-Blind, Placebo-controlled Study of the Efficacy & Safety of Monotherapy MORAb-004 Plus Best Supportive Care in Subjects With Chemorefractory Metastatic Colorectal Cancer
Status: Enrolling
Updated: 9/4/2015
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
Morphotek Investigation in Colorectal Cancer: Research of MORAb-004 (MICRO)
A Randomized, Double-Blind, Placebo-controlled Study of the Efficacy & Safety of Monotherapy MORAb-004 Plus Best Supportive Care in Subjects With Chemorefractory Metastatic Colorectal Cancer
Status: Enrolling
Updated:  9/4/2015
Regions Hospital
mi
from
Saint Louis Park, MN
Morphotek Investigation in Colorectal Cancer: Research of MORAb-004 (MICRO)
A Randomized, Double-Blind, Placebo-controlled Study of the Efficacy & Safety of Monotherapy MORAb-004 Plus Best Supportive Care in Subjects With Chemorefractory Metastatic Colorectal Cancer
Status: Enrolling
Updated: 9/4/2015
Regions Hospital
mi
from
Saint Louis Park, MN
Click here to add this to my saved trials
Morphotek Investigation in Colorectal Cancer: Research of MORAb-004 (MICRO)
A Randomized, Double-Blind, Placebo-controlled Study of the Efficacy & Safety of Monotherapy MORAb-004 Plus Best Supportive Care in Subjects With Chemorefractory Metastatic Colorectal Cancer
Status: Enrolling
Updated:  9/4/2015
Mercy Cancer Center
mi
from
Toledo, OH
Morphotek Investigation in Colorectal Cancer: Research of MORAb-004 (MICRO)
A Randomized, Double-Blind, Placebo-controlled Study of the Efficacy & Safety of Monotherapy MORAb-004 Plus Best Supportive Care in Subjects With Chemorefractory Metastatic Colorectal Cancer
Status: Enrolling
Updated: 9/4/2015
Mercy Cancer Center
mi
from
Toledo, OH
Click here to add this to my saved trials
Morphotek Investigation in Colorectal Cancer: Research of MORAb-004 (MICRO)
A Randomized, Double-Blind, Placebo-controlled Study of the Efficacy & Safety of Monotherapy MORAb-004 Plus Best Supportive Care in Subjects With Chemorefractory Metastatic Colorectal Cancer
Status: Enrolling
Updated:  9/4/2015
Fox Chase Cancer Center
mi
from
Philadelphia, PA
Morphotek Investigation in Colorectal Cancer: Research of MORAb-004 (MICRO)
A Randomized, Double-Blind, Placebo-controlled Study of the Efficacy & Safety of Monotherapy MORAb-004 Plus Best Supportive Care in Subjects With Chemorefractory Metastatic Colorectal Cancer
Status: Enrolling
Updated: 9/4/2015
Fox Chase Cancer Center
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Morphotek Investigation in Colorectal Cancer: Research of MORAb-004 (MICRO)
A Randomized, Double-Blind, Placebo-controlled Study of the Efficacy & Safety of Monotherapy MORAb-004 Plus Best Supportive Care in Subjects With Chemorefractory Metastatic Colorectal Cancer
Status: Enrolling
Updated:  9/4/2015
Miriam Hospital
mi
from
Providence, RI
Morphotek Investigation in Colorectal Cancer: Research of MORAb-004 (MICRO)
A Randomized, Double-Blind, Placebo-controlled Study of the Efficacy & Safety of Monotherapy MORAb-004 Plus Best Supportive Care in Subjects With Chemorefractory Metastatic Colorectal Cancer
Status: Enrolling
Updated: 9/4/2015
Miriam Hospital
mi
from
Providence, RI
Click here to add this to my saved trials
Effectiveness of MORAb-003 in Women With Ovarian Cancer Who Have Relapsed After Platinum-Based Chemotherapy
A Study of the Efficacy of MORAb-003 in Subjects With Platinum-Sensitive Epithelial Ovarian Cancer in First Relapse
Status: Enrolling
Updated:  9/4/2015
Sharp Healthcare
mi
from
San Diego, CA
Effectiveness of MORAb-003 in Women With Ovarian Cancer Who Have Relapsed After Platinum-Based Chemotherapy
A Study of the Efficacy of MORAb-003 in Subjects With Platinum-Sensitive Epithelial Ovarian Cancer in First Relapse
Status: Enrolling
Updated: 9/4/2015
Sharp Healthcare
mi
from
San Diego, CA
Click here to add this to my saved trials
Effectiveness of MORAb-003 in Women With Ovarian Cancer Who Have Relapsed After Platinum-Based Chemotherapy
A Study of the Efficacy of MORAb-003 in Subjects With Platinum-Sensitive Epithelial Ovarian Cancer in First Relapse
Status: Enrolling
Updated:  9/4/2015
St. Vincent Gynecologic Oncology
mi
from
Indianapolis, IN
Effectiveness of MORAb-003 in Women With Ovarian Cancer Who Have Relapsed After Platinum-Based Chemotherapy
A Study of the Efficacy of MORAb-003 in Subjects With Platinum-Sensitive Epithelial Ovarian Cancer in First Relapse
Status: Enrolling
Updated: 9/4/2015
St. Vincent Gynecologic Oncology
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Effectiveness of MORAb-003 in Women With Ovarian Cancer Who Have Relapsed After Platinum-Based Chemotherapy
A Study of the Efficacy of MORAb-003 in Subjects With Platinum-Sensitive Epithelial Ovarian Cancer in First Relapse
Status: Enrolling
Updated:  9/4/2015
Hematology and Oncology Specialists, LLC
mi
from
Covington, LA
Effectiveness of MORAb-003 in Women With Ovarian Cancer Who Have Relapsed After Platinum-Based Chemotherapy
A Study of the Efficacy of MORAb-003 in Subjects With Platinum-Sensitive Epithelial Ovarian Cancer in First Relapse
Status: Enrolling
Updated: 9/4/2015
Hematology and Oncology Specialists, LLC
mi
from
Covington, LA
Click here to add this to my saved trials
Effectiveness of MORAb-003 in Women With Ovarian Cancer Who Have Relapsed After Platinum-Based Chemotherapy
A Study of the Efficacy of MORAb-003 in Subjects With Platinum-Sensitive Epithelial Ovarian Cancer in First Relapse
Status: Enrolling
Updated:  9/4/2015
Jayne Gurtler, M.D.
mi
from
Metairie, LA
Effectiveness of MORAb-003 in Women With Ovarian Cancer Who Have Relapsed After Platinum-Based Chemotherapy
A Study of the Efficacy of MORAb-003 in Subjects With Platinum-Sensitive Epithelial Ovarian Cancer in First Relapse
Status: Enrolling
Updated: 9/4/2015
Jayne Gurtler, M.D.
mi
from
Metairie, LA
Click here to add this to my saved trials
Effectiveness of MORAb-003 in Women With Ovarian Cancer Who Have Relapsed After Platinum-Based Chemotherapy
A Study of the Efficacy of MORAb-003 in Subjects With Platinum-Sensitive Epithelial Ovarian Cancer in First Relapse
Status: Enrolling
Updated:  9/4/2015
Hematology and Oncology Specialists, LLC
mi
from
Metarie, LA
Effectiveness of MORAb-003 in Women With Ovarian Cancer Who Have Relapsed After Platinum-Based Chemotherapy
A Study of the Efficacy of MORAb-003 in Subjects With Platinum-Sensitive Epithelial Ovarian Cancer in First Relapse
Status: Enrolling
Updated: 9/4/2015
Hematology and Oncology Specialists, LLC
mi
from
Metarie, LA
Click here to add this to my saved trials
Effectiveness of MORAb-003 in Women With Ovarian Cancer Who Have Relapsed After Platinum-Based Chemotherapy
A Study of the Efficacy of MORAb-003 in Subjects With Platinum-Sensitive Epithelial Ovarian Cancer in First Relapse
Status: Enrolling
Updated:  9/4/2015
Johns Hopkins University
mi
from
Baltimore, MD
Effectiveness of MORAb-003 in Women With Ovarian Cancer Who Have Relapsed After Platinum-Based Chemotherapy
A Study of the Efficacy of MORAb-003 in Subjects With Platinum-Sensitive Epithelial Ovarian Cancer in First Relapse
Status: Enrolling
Updated: 9/4/2015
Johns Hopkins University
mi
from
Baltimore, MD
Click here to add this to my saved trials
Effectiveness of MORAb-003 in Women With Ovarian Cancer Who Have Relapsed After Platinum-Based Chemotherapy
A Study of the Efficacy of MORAb-003 in Subjects With Platinum-Sensitive Epithelial Ovarian Cancer in First Relapse
Status: Enrolling
Updated:  9/4/2015
The Center for Cancer and Hematologic Disease
mi
from
Cherry Hill, NJ
Effectiveness of MORAb-003 in Women With Ovarian Cancer Who Have Relapsed After Platinum-Based Chemotherapy
A Study of the Efficacy of MORAb-003 in Subjects With Platinum-Sensitive Epithelial Ovarian Cancer in First Relapse
Status: Enrolling
Updated: 9/4/2015
The Center for Cancer and Hematologic Disease
mi
from
Cherry Hill, NJ
Click here to add this to my saved trials
Effectiveness of MORAb-003 in Women With Ovarian Cancer Who Have Relapsed After Platinum-Based Chemotherapy
A Study of the Efficacy of MORAb-003 in Subjects With Platinum-Sensitive Epithelial Ovarian Cancer in First Relapse
Status: Enrolling
Updated:  9/4/2015
The Cancer Institute of New Jersey
mi
from
New Brunswick, NJ
Effectiveness of MORAb-003 in Women With Ovarian Cancer Who Have Relapsed After Platinum-Based Chemotherapy
A Study of the Efficacy of MORAb-003 in Subjects With Platinum-Sensitive Epithelial Ovarian Cancer in First Relapse
Status: Enrolling
Updated: 9/4/2015
The Cancer Institute of New Jersey
mi
from
New Brunswick, NJ
Click here to add this to my saved trials
Effectiveness of MORAb-003 in Women With Ovarian Cancer Who Have Relapsed After Platinum-Based Chemotherapy
A Study of the Efficacy of MORAb-003 in Subjects With Platinum-Sensitive Epithelial Ovarian Cancer in First Relapse
Status: Enrolling
Updated:  9/4/2015
Cooper University Hospital
mi
from
Voorhees, NJ
Effectiveness of MORAb-003 in Women With Ovarian Cancer Who Have Relapsed After Platinum-Based Chemotherapy
A Study of the Efficacy of MORAb-003 in Subjects With Platinum-Sensitive Epithelial Ovarian Cancer in First Relapse
Status: Enrolling
Updated: 9/4/2015
Cooper University Hospital
mi
from
Voorhees, NJ
Click here to add this to my saved trials
Effectiveness of MORAb-003 in Women With Ovarian Cancer Who Have Relapsed After Platinum-Based Chemotherapy
A Study of the Efficacy of MORAb-003 in Subjects With Platinum-Sensitive Epithelial Ovarian Cancer in First Relapse
Status: Enrolling
Updated:  9/4/2015
New York Oncology Hematology PC
mi
from
Albany, NY
Effectiveness of MORAb-003 in Women With Ovarian Cancer Who Have Relapsed After Platinum-Based Chemotherapy
A Study of the Efficacy of MORAb-003 in Subjects With Platinum-Sensitive Epithelial Ovarian Cancer in First Relapse
Status: Enrolling
Updated: 9/4/2015
New York Oncology Hematology PC
mi
from
Albany, NY
Click here to add this to my saved trials
Effectiveness of MORAb-003 in Women With Ovarian Cancer Who Have Relapsed After Platinum-Based Chemotherapy
A Study of the Efficacy of MORAb-003 in Subjects With Platinum-Sensitive Epithelial Ovarian Cancer in First Relapse
Status: Enrolling
Updated:  9/4/2015
Gabrail Cancer Center
mi
from
Canton, OH
Effectiveness of MORAb-003 in Women With Ovarian Cancer Who Have Relapsed After Platinum-Based Chemotherapy
A Study of the Efficacy of MORAb-003 in Subjects With Platinum-Sensitive Epithelial Ovarian Cancer in First Relapse
Status: Enrolling
Updated: 9/4/2015
Gabrail Cancer Center
mi
from
Canton, OH
Click here to add this to my saved trials
Effectiveness of MORAb-003 in Women With Ovarian Cancer Who Have Relapsed After Platinum-Based Chemotherapy
A Study of the Efficacy of MORAb-003 in Subjects With Platinum-Sensitive Epithelial Ovarian Cancer in First Relapse
Status: Enrolling
Updated:  9/4/2015
Lehigh Valley Women's Cancer Center
mi
from
Allentown, PA
Effectiveness of MORAb-003 in Women With Ovarian Cancer Who Have Relapsed After Platinum-Based Chemotherapy
A Study of the Efficacy of MORAb-003 in Subjects With Platinum-Sensitive Epithelial Ovarian Cancer in First Relapse
Status: Enrolling
Updated: 9/4/2015
Lehigh Valley Women's Cancer Center
mi
from
Allentown, PA
Click here to add this to my saved trials
Effectiveness of MORAb-003 in Women With Ovarian Cancer Who Have Relapsed After Platinum-Based Chemotherapy
A Study of the Efficacy of MORAb-003 in Subjects With Platinum-Sensitive Epithelial Ovarian Cancer in First Relapse
Status: Enrolling
Updated:  9/4/2015
Gynecology Oncology Research & Development
mi
from
Greenville, SC
Effectiveness of MORAb-003 in Women With Ovarian Cancer Who Have Relapsed After Platinum-Based Chemotherapy
A Study of the Efficacy of MORAb-003 in Subjects With Platinum-Sensitive Epithelial Ovarian Cancer in First Relapse
Status: Enrolling
Updated: 9/4/2015
Gynecology Oncology Research & Development
mi
from
Greenville, SC
Click here to add this to my saved trials
Effectiveness of MORAb-003 in Women With Ovarian Cancer Who Have Relapsed After Platinum-Based Chemotherapy
A Study of the Efficacy of MORAb-003 in Subjects With Platinum-Sensitive Epithelial Ovarian Cancer in First Relapse
Status: Enrolling
Updated:  9/4/2015
Mary Crowley Medical Research Center
mi
from
Dallas, TX
Effectiveness of MORAb-003 in Women With Ovarian Cancer Who Have Relapsed After Platinum-Based Chemotherapy
A Study of the Efficacy of MORAb-003 in Subjects With Platinum-Sensitive Epithelial Ovarian Cancer in First Relapse
Status: Enrolling
Updated: 9/4/2015
Mary Crowley Medical Research Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Effectiveness of MORAb-003 in Women With Ovarian Cancer Who Have Relapsed After Platinum-Based Chemotherapy
A Study of the Efficacy of MORAb-003 in Subjects With Platinum-Sensitive Epithelial Ovarian Cancer in First Relapse
Status: Enrolling
Updated:  9/4/2015
South Texas Oncology and Hematology
mi
from
San Antonio, TX
Effectiveness of MORAb-003 in Women With Ovarian Cancer Who Have Relapsed After Platinum-Based Chemotherapy
A Study of the Efficacy of MORAb-003 in Subjects With Platinum-Sensitive Epithelial Ovarian Cancer in First Relapse
Status: Enrolling
Updated: 9/4/2015
South Texas Oncology and Hematology
mi
from
San Antonio, TX
Click here to add this to my saved trials
Effectiveness of MORAb-003 in Women With Ovarian Cancer Who Have Relapsed After Platinum-Based Chemotherapy
A Study of the Efficacy of MORAb-003 in Subjects With Platinum-Sensitive Epithelial Ovarian Cancer in First Relapse
Status: Enrolling
Updated:  9/4/2015
Tyler Cancer Center
mi
from
Tyler, TX
Effectiveness of MORAb-003 in Women With Ovarian Cancer Who Have Relapsed After Platinum-Based Chemotherapy
A Study of the Efficacy of MORAb-003 in Subjects With Platinum-Sensitive Epithelial Ovarian Cancer in First Relapse
Status: Enrolling
Updated: 9/4/2015
Tyler Cancer Center
mi
from
Tyler, TX
Click here to add this to my saved trials
Effectiveness of MORAb-003 in Women With Ovarian Cancer Who Have Relapsed After Platinum-Based Chemotherapy
A Study of the Efficacy of MORAb-003 in Subjects With Platinum-Sensitive Epithelial Ovarian Cancer in First Relapse
Status: Enrolling
Updated:  9/4/2015
Northern Virginia Pelvic Surgery Associates
mi
from
Annandale, VA
Effectiveness of MORAb-003 in Women With Ovarian Cancer Who Have Relapsed After Platinum-Based Chemotherapy
A Study of the Efficacy of MORAb-003 in Subjects With Platinum-Sensitive Epithelial Ovarian Cancer in First Relapse
Status: Enrolling
Updated: 9/4/2015
Northern Virginia Pelvic Surgery Associates
mi
from
Annandale, VA
Click here to add this to my saved trials
Effectiveness of MORAb-003 in Women With Ovarian Cancer Who Have Relapsed After Platinum-Based Chemotherapy
A Study of the Efficacy of MORAb-003 in Subjects With Platinum-Sensitive Epithelial Ovarian Cancer in First Relapse
Status: Enrolling
Updated:  9/4/2015
Peninsula Cancer Center
mi
from
Newport News, VA
Effectiveness of MORAb-003 in Women With Ovarian Cancer Who Have Relapsed After Platinum-Based Chemotherapy
A Study of the Efficacy of MORAb-003 in Subjects With Platinum-Sensitive Epithelial Ovarian Cancer in First Relapse
Status: Enrolling
Updated: 9/4/2015
Peninsula Cancer Center
mi
from
Newport News, VA
Click here to add this to my saved trials
Effectiveness of MORAb-003 in Women With Ovarian Cancer Who Have Relapsed After Platinum-Based Chemotherapy
A Study of the Efficacy of MORAb-003 in Subjects With Platinum-Sensitive Epithelial Ovarian Cancer in First Relapse
Status: Enrolling
Updated:  9/4/2015
Krankenhaus Nordwest
mi
from
Frankfurt,
Effectiveness of MORAb-003 in Women With Ovarian Cancer Who Have Relapsed After Platinum-Based Chemotherapy
A Study of the Efficacy of MORAb-003 in Subjects With Platinum-Sensitive Epithelial Ovarian Cancer in First Relapse
Status: Enrolling
Updated: 9/4/2015
Krankenhaus Nordwest
mi
from
Frankfurt,
Click here to add this to my saved trials
An Efficacy Study of MORAb-009 in Subjects With Pancreatic Cancer
A Phase 2 Randomized, Placebo-controlled, Double-blind Study of the Efficacy of MORAb-009 in Combination With Gemcitabine in Patients With Advanced Pancreatic Cancer.
Status: Enrolling
Updated:  9/4/2015
Moores UCSD Cancer Center
mi
from
La Jolla, CA
An Efficacy Study of MORAb-009 in Subjects With Pancreatic Cancer
A Phase 2 Randomized, Placebo-controlled, Double-blind Study of the Efficacy of MORAb-009 in Combination With Gemcitabine in Patients With Advanced Pancreatic Cancer.
Status: Enrolling
Updated: 9/4/2015
Moores UCSD Cancer Center
mi
from
La Jolla, CA
Click here to add this to my saved trials
An Efficacy Study of MORAb-009 in Subjects With Pancreatic Cancer
A Phase 2 Randomized, Placebo-controlled, Double-blind Study of the Efficacy of MORAb-009 in Combination With Gemcitabine in Patients With Advanced Pancreatic Cancer.
Status: Enrolling
Updated:  9/4/2015
Southern California Permanente Medical Group
mi
from
San Diego, CA
An Efficacy Study of MORAb-009 in Subjects With Pancreatic Cancer
A Phase 2 Randomized, Placebo-controlled, Double-blind Study of the Efficacy of MORAb-009 in Combination With Gemcitabine in Patients With Advanced Pancreatic Cancer.
Status: Enrolling
Updated: 9/4/2015
Southern California Permanente Medical Group
mi
from
San Diego, CA
Click here to add this to my saved trials
An Efficacy Study of MORAb-009 in Subjects With Pancreatic Cancer
A Phase 2 Randomized, Placebo-controlled, Double-blind Study of the Efficacy of MORAb-009 in Combination With Gemcitabine in Patients With Advanced Pancreatic Cancer.
Status: Enrolling
Updated:  9/4/2015
Sharp Memorial Hospital
mi
from
San Diego, CA
An Efficacy Study of MORAb-009 in Subjects With Pancreatic Cancer
A Phase 2 Randomized, Placebo-controlled, Double-blind Study of the Efficacy of MORAb-009 in Combination With Gemcitabine in Patients With Advanced Pancreatic Cancer.
Status: Enrolling
Updated: 9/4/2015
Sharp Memorial Hospital
mi
from
San Diego, CA
Click here to add this to my saved trials
An Efficacy Study of MORAb-009 in Subjects With Pancreatic Cancer
A Phase 2 Randomized, Placebo-controlled, Double-blind Study of the Efficacy of MORAb-009 in Combination With Gemcitabine in Patients With Advanced Pancreatic Cancer.
Status: Enrolling
Updated:  9/4/2015
Kaiser Permanente
mi
from
Vallejo, CA
An Efficacy Study of MORAb-009 in Subjects With Pancreatic Cancer
A Phase 2 Randomized, Placebo-controlled, Double-blind Study of the Efficacy of MORAb-009 in Combination With Gemcitabine in Patients With Advanced Pancreatic Cancer.
Status: Enrolling
Updated: 9/4/2015
Kaiser Permanente
mi
from
Vallejo, CA
Click here to add this to my saved trials
An Efficacy Study of MORAb-009 in Subjects With Pancreatic Cancer
A Phase 2 Randomized, Placebo-controlled, Double-blind Study of the Efficacy of MORAb-009 in Combination With Gemcitabine in Patients With Advanced Pancreatic Cancer.
Status: Enrolling
Updated:  9/4/2015
Cancer Center of Central Connecticut
mi
from
Southington, CT
An Efficacy Study of MORAb-009 in Subjects With Pancreatic Cancer
A Phase 2 Randomized, Placebo-controlled, Double-blind Study of the Efficacy of MORAb-009 in Combination With Gemcitabine in Patients With Advanced Pancreatic Cancer.
Status: Enrolling
Updated: 9/4/2015
Cancer Center of Central Connecticut
mi
from
Southington, CT
Click here to add this to my saved trials
An Efficacy Study of MORAb-009 in Subjects With Pancreatic Cancer
A Phase 2 Randomized, Placebo-controlled, Double-blind Study of the Efficacy of MORAb-009 in Combination With Gemcitabine in Patients With Advanced Pancreatic Cancer.
Status: Enrolling
Updated:  9/4/2015
Connecticut Oncology & Hematology
mi
from
Torrington, CT
An Efficacy Study of MORAb-009 in Subjects With Pancreatic Cancer
A Phase 2 Randomized, Placebo-controlled, Double-blind Study of the Efficacy of MORAb-009 in Combination With Gemcitabine in Patients With Advanced Pancreatic Cancer.
Status: Enrolling
Updated: 9/4/2015
Connecticut Oncology & Hematology
mi
from
Torrington, CT
Click here to add this to my saved trials
An Efficacy Study of MORAb-009 in Subjects With Pancreatic Cancer
A Phase 2 Randomized, Placebo-controlled, Double-blind Study of the Efficacy of MORAb-009 in Combination With Gemcitabine in Patients With Advanced Pancreatic Cancer.
Status: Enrolling
Updated:  9/4/2015
Palm Beach Institute of Hematology and Oncology
mi
from
Boynton Beach, FL
An Efficacy Study of MORAb-009 in Subjects With Pancreatic Cancer
A Phase 2 Randomized, Placebo-controlled, Double-blind Study of the Efficacy of MORAb-009 in Combination With Gemcitabine in Patients With Advanced Pancreatic Cancer.
Status: Enrolling
Updated: 9/4/2015
Palm Beach Institute of Hematology and Oncology
mi
from
Boynton Beach, FL
Click here to add this to my saved trials
An Efficacy Study of MORAb-009 in Subjects With Pancreatic Cancer
A Phase 2 Randomized, Placebo-controlled, Double-blind Study of the Efficacy of MORAb-009 in Combination With Gemcitabine in Patients With Advanced Pancreatic Cancer.
Status: Enrolling
Updated:  9/4/2015
Baptist Cancer Institute - Jacksonville
mi
from
Jacksonville, FL
An Efficacy Study of MORAb-009 in Subjects With Pancreatic Cancer
A Phase 2 Randomized, Placebo-controlled, Double-blind Study of the Efficacy of MORAb-009 in Combination With Gemcitabine in Patients With Advanced Pancreatic Cancer.
Status: Enrolling
Updated: 9/4/2015
Baptist Cancer Institute - Jacksonville
mi
from
Jacksonville, FL
Click here to add this to my saved trials
An Efficacy Study of MORAb-009 in Subjects With Pancreatic Cancer
A Phase 2 Randomized, Placebo-controlled, Double-blind Study of the Efficacy of MORAb-009 in Combination With Gemcitabine in Patients With Advanced Pancreatic Cancer.
Status: Enrolling
Updated:  9/4/2015
Hematology Oncology Associates of the Palm Beaches
mi
from
Lake Worth, FL
An Efficacy Study of MORAb-009 in Subjects With Pancreatic Cancer
A Phase 2 Randomized, Placebo-controlled, Double-blind Study of the Efficacy of MORAb-009 in Combination With Gemcitabine in Patients With Advanced Pancreatic Cancer.
Status: Enrolling
Updated: 9/4/2015
Hematology Oncology Associates of the Palm Beaches
mi
from
Lake Worth, FL
Click here to add this to my saved trials
An Efficacy Study of MORAb-009 in Subjects With Pancreatic Cancer
A Phase 2 Randomized, Placebo-controlled, Double-blind Study of the Efficacy of MORAb-009 in Combination With Gemcitabine in Patients With Advanced Pancreatic Cancer.
Status: Enrolling
Updated:  9/4/2015
Hematology Oncology Associates of Illinois
mi
from
Skokie, IL
An Efficacy Study of MORAb-009 in Subjects With Pancreatic Cancer
A Phase 2 Randomized, Placebo-controlled, Double-blind Study of the Efficacy of MORAb-009 in Combination With Gemcitabine in Patients With Advanced Pancreatic Cancer.
Status: Enrolling
Updated: 9/4/2015
Hematology Oncology Associates of Illinois
mi
from
Skokie, IL
Click here to add this to my saved trials
An Efficacy Study of MORAb-009 in Subjects With Pancreatic Cancer
A Phase 2 Randomized, Placebo-controlled, Double-blind Study of the Efficacy of MORAb-009 in Combination With Gemcitabine in Patients With Advanced Pancreatic Cancer.
Status: Enrolling
Updated:  9/4/2015
Carle Clinic Assoc.
mi
from
Urbana, IL
An Efficacy Study of MORAb-009 in Subjects With Pancreatic Cancer
A Phase 2 Randomized, Placebo-controlled, Double-blind Study of the Efficacy of MORAb-009 in Combination With Gemcitabine in Patients With Advanced Pancreatic Cancer.
Status: Enrolling
Updated: 9/4/2015
Carle Clinic Assoc.
mi
from
Urbana, IL
Click here to add this to my saved trials
An Efficacy Study of MORAb-009 in Subjects With Pancreatic Cancer
A Phase 2 Randomized, Placebo-controlled, Double-blind Study of the Efficacy of MORAb-009 in Combination With Gemcitabine in Patients With Advanced Pancreatic Cancer.
Status: Enrolling
Updated:  9/4/2015
University of Kansas Medical Center
mi
from
Westwood, KA
An Efficacy Study of MORAb-009 in Subjects With Pancreatic Cancer
A Phase 2 Randomized, Placebo-controlled, Double-blind Study of the Efficacy of MORAb-009 in Combination With Gemcitabine in Patients With Advanced Pancreatic Cancer.
Status: Enrolling
Updated: 9/4/2015
University of Kansas Medical Center
mi
from
Westwood, KA
Click here to add this to my saved trials
An Efficacy Study of MORAb-009 in Subjects With Pancreatic Cancer
A Phase 2 Randomized, Placebo-controlled, Double-blind Study of the Efficacy of MORAb-009 in Combination With Gemcitabine in Patients With Advanced Pancreatic Cancer.
Status: Enrolling
Updated:  9/4/2015
Jayne Gurtler, MD, Laura Brinz, MD, & Angelo Russo, MD
mi
from
Metairie, LA
An Efficacy Study of MORAb-009 in Subjects With Pancreatic Cancer
A Phase 2 Randomized, Placebo-controlled, Double-blind Study of the Efficacy of MORAb-009 in Combination With Gemcitabine in Patients With Advanced Pancreatic Cancer.
Status: Enrolling
Updated: 9/4/2015
Jayne Gurtler, MD, Laura Brinz, MD, & Angelo Russo, MD
mi
from
Metairie, LA
Click here to add this to my saved trials
An Efficacy Study of MORAb-009 in Subjects With Pancreatic Cancer
A Phase 2 Randomized, Placebo-controlled, Double-blind Study of the Efficacy of MORAb-009 in Combination With Gemcitabine in Patients With Advanced Pancreatic Cancer.
Status: Enrolling
Updated:  9/4/2015
Providence Cancer Center, Oncology, Clinical Trials
mi
from
Southfield, MI
An Efficacy Study of MORAb-009 in Subjects With Pancreatic Cancer
A Phase 2 Randomized, Placebo-controlled, Double-blind Study of the Efficacy of MORAb-009 in Combination With Gemcitabine in Patients With Advanced Pancreatic Cancer.
Status: Enrolling
Updated: 9/4/2015
Providence Cancer Center, Oncology, Clinical Trials
mi
from
Southfield, MI
Click here to add this to my saved trials
An Efficacy Study of MORAb-009 in Subjects With Pancreatic Cancer
A Phase 2 Randomized, Placebo-controlled, Double-blind Study of the Efficacy of MORAb-009 in Combination With Gemcitabine in Patients With Advanced Pancreatic Cancer.
Status: Enrolling
Updated:  9/4/2015
The Center for Cancer and Hematologic Disease
mi
from
Cherry Hill, NJ
An Efficacy Study of MORAb-009 in Subjects With Pancreatic Cancer
A Phase 2 Randomized, Placebo-controlled, Double-blind Study of the Efficacy of MORAb-009 in Combination With Gemcitabine in Patients With Advanced Pancreatic Cancer.
Status: Enrolling
Updated: 9/4/2015
The Center for Cancer and Hematologic Disease
mi
from
Cherry Hill, NJ
Click here to add this to my saved trials